However, blocking FASL in malignant T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoma lines has been demonstrated to substantially decrease cytotoxicity caused by CD5-specific CAR T cells, highlighting the importance of the FAS-FASL mechanism [11]. This evidence concerns the gene FASLG and T-cell non-Hodgkin lymphoma.